Should Primary Percutaneous Coronary Intervention Be the Preferred Method of Reperfusion Therapy for Patients With Renal Failure and ST-Elevation Acute Myocardial Infarction?

American Journal of Cardiology

Volumn 97, Issue 8, 2006, Pages 1142-1145

  Dragu, Robert ^a   Behar, Solomon ^b   Sandach, Amir ^b   Boyko, Valentina ^b   Kapeliovich, Michael ^a   Rispler, Shmuel ^a   Hammerman, Haim ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

^b Israeli Society for the Prevention of Heart Attacks Tel Hashomer   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; HEART MUSCLE REPERFUSION; HUMAN; ISRAEL; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; ST SEGMENT ELEVATION; TREATMENT PLANNING;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ELECTROCARDIOGRAPHY; FEMALE; FIBRINOLYTIC AGENTS; HEALTH SURVEYS; HUMANS; KIDNEY FAILURE; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; PATIENT READMISSION; PLASMINOGEN ACTIVATORS; PROSPECTIVE STUDIES; STREPTOKINASE; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 33645735285     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.11.028     Document Type: Article

References (13)

1. Best P.J., Lennon R., Ting H.H., Bell M.R., Rihal C.S., Holmes D.R., and Berger P.B. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 39 (2002) 1113-1119
2. Shaw R.E., Anderson H.V., Brindis R.G., Krone R.J., Klein L.W., McKay C.R., Block P.C., Shaw L.J., Hewitt K., and Weintraub W.S. Development of a risk adjustment mortality model using the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR) experience. 1998-2000. J Am Coll Cardiol 39 (2002) 1104-1112
3. Rubenstein M.H., Sheynberg B.V., Harrell L.C., Schunkert H., Bazari H., and Palacios I.F. Effectiveness of and adverse events after percutaneous coronary intervention in patients with mild versus severe renal failure. Am J Cardiol 87 (2001) 856-860
4. Reinecke H., Trey T., Matzkies F., Fobker M., Breithardt G., and Schaefer R.M. Grade of chronic renal failure, and acute and long-term outcome after percutaneous coronary interventions. Kidney Int 63 (2003) 696-701
5. Szczech L.A., Reddan D.N., Owen W.F., Califf R., Racz M., Jones R.H., and Hannan E.L. Differential survival after coronary revascularization procedures among patients with renal insufficiency. Kidney Int 60 (2001) 292-299
6. Gruberg L., Dangas G., Mehran R., Mintz G.S., Kent K.M., Pichard A.D., Satler L.F., Lansky A.J., Stone G.W., and Leon M.B. Clinical outcome following percutaneous coronary interventions in patients with chronic renal failure. Catheter Cardiovasc Interv 55 (2002) 66-72
7. Gruberg L., Mehran R., Dangas G., Mintz G.S., Waksman R., Kent K.M., Pichard A.D., Satler L.F., Wu H., and Leon M.B. Acute renal failure requiring dialysis after percutaneous coronary interventions. Catheter Cardiovasc Interv 52 (2001) 409-416
8. Fernandez J.S., and Sadaniantz A. Medical and revascularization management in acute coronary syndrome in renal patients. Semin Nephrol 21 (2001) 25-35
9. Gibson C.M., Pinto D.S., Murphy S.A., Morrow D.A., Hobbach H.P., Wiviott S.D., Giugliano R.P., Cannon C.P., Antman E.M., and Braunwald E. Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality. J Am Coll Cardiol 42 (2003) 1535-1543
10. Sadeghi H.M., Stone G.W., Grines C.L., Mehran R., Dixon S.R., Lansky A.J., Fahy M., Cox D.A., Garcia E., Tcheng J.E., et al. Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction. Circulation 108 (2003) 2769-2775
11. Freeman R.V., O'Donnell M., Share D., Meengs W.L., Kline-Rogers E., Clark V.L., DeFranco A.C., Eagle K.A., McGinnity J.G., Patel K., et al. Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose. Am J Cardiol 90 (2002) 1068-1073
12. Freeman R.V., Mehta R.H., Al Badr W., Cooper J.V., Kline-Rogers E., and Eagle K.A. Influence of concurrent renal dysfunction on outcomes of patients with acute coronary syndromes and implications of the use of glycoprotein IIb/IIIa inhibitors. J Am Coll Cardiol 41 (2003) 718-724
13. Gruberg L., Weissman N.J., Pichard A.D., Waksman R., Kent K.M., Satler L.F., Suddath W.O., Pinnow E.E., Gevorkian N., and Lindsay Jr. J. Impact of renal function on morbidity and mortality after percutaneous aortocoronary saphenous vein graft intervention. Am Heart J 145 (2003) 529-534